Until sensitive and specific biomarkers for CTE p-tau pathology are available, a diagnosis of TES dementia “consistent with CTE” could be considered in older individuals with a substantial history of RHI exposure, progressive cognitive decline, and functional impairment who have negative amyloid PET imaging. This evidence concerns the gene MAPT and Mental deterioration.